TABLE 2.
Treatments
|
|||||
---|---|---|---|---|---|
SHAM | OVX-0 | OVX-50 | OVX-100 | OVX-200 | |
Mammary tissue | |||||
Gland proliferation | 1.94 ± 0.570a | 0.53 ± 0.740b | 0.38 ± 0.50b | 0.47 ± 0.510b | 0.94 ± 0.570b |
PCNA, % | 14.8 ± 15.3a | 1.98 ± 2.11b | 1.14 ± 1.66b | 2.32 ± 3.72b | 2.59 ± 4.70b |
Uterine tissue | |||||
Epithelial proliferation | 1.94 ± 0.770a | 0.000 ± 0.000c | 0.130 ± 0.340c | 0.330 ± 0.490bc | 0.750 ± 0.580b |
Epithelial PCNA, % | 37.6 ± 21.8a | 1.14 ± 2.09b | 0.670 ± 1.15b | 8.95 ± 12.4a | 15.3 ± 18.0a |
Stroma PCNA, % | 19.2 ± 21.1a | 0.650 ± 1.45b | 0.920 ± 1.92b | 2.67 ± 2.99ab | 4.18 ± 3.98a |
Values are means ± SD, n = 15–16. Means without a common letter differ, P < 0.05.